A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)

NCT00541463 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: MK0639, indinavir sulfate / Duration of Treatment: 48 Weeks
DRUG: Comparator: nelfinavir mesylate / Duration of Treatment: 48 Weeks

Sponsor

Merck Sharp & Dohme LLC